Ignite Creation Date:
2024-05-06 @ 3:56 PM
Last Modification Date:
2024-10-26 @ 2:00 PM
Study NCT ID:
NCT04812483
Status:
COMPLETED
Last Update Posted:
2024-01-17
First Post:
2021-03-01
Brief Title:
Immunomodulation With Eltrombopag in ITP
Sponsor:
University Childrens Hospital Basel
Organization:
University Childrens Hospital Basel
Organization Data
Organization:
University Childrens Hospital Basel
Class:
OTHER
Study ID:
2021-00044 ks19Schifferli
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Childrens Hospital Basel
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| University of Erlangen-Nürnberg Department of Biology | UNKNOWN |
| Stiftung zur Förderung medizinischer und biologischer Forschung | UNKNOWN |
| Novartis Pharmaceuticals | INDUSTRY |